Related Experiment Video
Updated: Jan 28, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
893
The Canadian pediatric surgery workforce: A 5-year prospective study
Sherif Emil1, Jacob C Langer2, Geoffrey Blair3
1Department of Pediatric Surgery, McGill University Faculty of Medicine &The Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Journal of Pediatric Surgery
|February 24, 2019
Summary
Canadian pediatric surgery workforce predictions were accurate, showing modest growth. However, a gap persists between trained surgeons and available positions, impacting workforce planning.
Area of Science:
- Medical Workforce Analysis
- Pediatric Surgery Workforce Dynamics
Background:
- A 2014 survey predicted a need for 2 new pediatric surgeons annually in Canada.
- This study aimed to validate those predictions and assess the current Canadian pediatric surgery workforce status.
Purpose of the Study:
- To evaluate the accuracy of 2014 workforce predictions for Canadian pediatric surgeons.
- To assess the current state and trends of the pediatric surgery workforce in Canada.
Main Methods:
- Annual web-based surveys were administered to Canadian pediatric surgery division chiefs from 2013 to 2017.
- Data collected included the number of practicing surgeons, full-time equivalent (FTE) positions, and fellowship graduates.
Main Results:
- The number of practicing pediatric surgeons increased from 73 to 78, and FTE positions grew from 64.6 to 67.5 between 2013 and 2017.
- While 18 positions were filled, including by international surgeons, 38 fellows trained in Canada, with 24 non-Canadians leaving the country.
- Nine Canadian fellows took positions in Canada (5) and the US (4), highlighting a continued mismatch.
Conclusions:
- The 2014 workforce predictions were largely accurate, indicating modest growth in the Canadian pediatric surgery workforce over five years.
- A significant discrepancy remains between the number of Canadian pediatric surgery graduates and available attending staff positions.
Related Concept Videos
01:045-Number Summary
5.7K
In a dataset, the 5-number summary includes the minimum data value, the data value of the first quartile, the median data value or data value of the second quartile, the data value of the third quartile, and the maximum data value. These 5 data values can be visualized as a box and whisker plot.
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
5.7K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
213
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
272
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
656
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
656